Tag: Zydus Cadila vaccine
DCGI gives permission to conduct Phase III trial for two-dose C-19...
India’s drug regulator Drugs Controller General of India (DCGI) has given permission to Zydus Cadila for conducting Phase III trial on the two-dose regimen...
Latest posts
IPC flags safety alert against immunosuppressive drug Tacrolimus
The Indian Pharmacopoeia Commission (IPC), which is the National Coordination Centre (NCC) for the Pharmacovigilance Programme of India (PvPI), has flagged a...
Authors
